Juventas Therapeutics' Debt - II Round

Juventas Therapeutics raised a round of funding on October 04, 2017.

Juventas Therapeutics, formerly AcelleRx Therapeutics, Juventas Therapeutics is a privately held, clinical stage biotechnology company focused on developing non-viral gene therapies to treat advanced …

Articles about Juventas Therapeutics' Debt - II Round: